Phase I/II Study of Docetaxel and S-1 in Previously-Treated Patients with Advanced Non-Small Cell Lung Cancer: LOGIK0408

Background: As docetaxel plus S-1 may be feasible for cancer treatment, we conducted a phase I/II trial to determine the recommended docetaxel dose and the fixed S-1 dose (phase I), as well as confirm the regimen’s efficacy and safety (phase II) for previously-treated patients with advanced non-smal...

Descripción completa

Detalles Bibliográficos
Autores principales: Takayama, Koichi, Uchino, Junji, Fujita, Masaki, Tokunaga, Shoji, Imanaga, Tomotoshi, Morinaga, Ryotaro, Ebi, Noriyuki, Saeki, Sho, Matsukizono, Kazuya, Wataya, Hiroshi, Yamada, Tadaaki, Nakanishi, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947543/
https://www.ncbi.nlm.nih.gov/pubmed/31842381
http://dx.doi.org/10.3390/jcm8122196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947543/
https://www.ncbi.nlm.nih.gov/pubmed/31842381
http://dx.doi.org/10.3390/jcm8122196

Ejemplares similares